#WCE2014 - Patients with BMI > 60 have equivalent outcomes after percutaneous nephrolithotomy compared to super and morbidly obese patients: Single center study - Session Highlights

TAIPEI, TAIWAN (UroToday.com) - Obesity is a risk factor for many adverse events in patients undergoing abdominal and urologic surgical procedures. In addition, it is a known risk factor for recurrent nephrolithiasis. Percutaneous nephrolithotomy (PCNL) has previously been shown to be safe in the obese (BMI 30–34.9), and severely obese (BMI 35–39.9); however, there is limited evidence supporting its use in morbidly (BMI 40–44.9) or super obese patients with the BMI of 45 and above.

wceDr. Necole Streeper’s group from the University of Wisconsin performed a retrospective review of 67 cases with a BMI of 40 who underwent PCNL. Patients were divided into different groups according to their BMI of 40–49.9, 50–59.9, and > 60, and outcomes were compared. The variables evaluated included operative time, length of hospital stay, stone burden, complication rate, and stone-free rate. Stone burden was measured on preoperative CT scans.

Baseline stone volume was similar among all groups. The overall stone-free rate after a single procedure was 72%, with a complication rate of 10%, which is lower than that reported in the literature. No statistically significant differences were revealed across all BMI subgroups with respect to length of hospital stay, complications, and stone-free rate.

The authors concluded that the BMI > 60 does not impact the PCNL outcomes. The complication rate, length of hospital stay, or stone-free rate is equal in all patients. There may be a relationship between BMI and adjunct procedures to achieve comparable stone-free status.

Presented by Necole M. Streeper, Andrew C. Radtke, Kristina L. Penniston, and Stephen Y. Nakada at the 32nd World Congress of Endourology & SWL - September 3 - 7, 2014 - Taipei, Taiwan

University of Wisconsin School of Medicine and Public Health, Madison, WI USA

Written by Zhamshid Okhunov, MD, Department of Urology, School of Medicine, University of California-Irvine, and medical writer for UroToday.com

 

 

Conference Coverage
 
Recent data from conferences worldwide
  • 2020 Virtual Congress / September 19-21
  • 2020 BCAN Think Tank Virtual / August 7
  • 2020 Virtual Education Program / August 8-10
  • 2020 Annual Meeting / July 17-19 / EAU Virtual Program
  • SUO - AUA 2020 Summer Webcast / July 18
  • 2020 Annual Meeting / June 27-28 / AUA Live Virtual Program
  • 2020 Annual Meeting / May 29-31 / Virtual Scientific Program
  • 2020 Annual Meeting / February 13-15 / San Francisco, CA
  • 2019 Annual Meeting / December 4-6 / Washington, DC
  • 2019 Annual Meeting / October 3 - October 5 / Aarhus, Denmark
  • 2019 Annual Congress / September 27 - October 1 / Barcelona, Spain
  • 2019 Biennial Meeting / August 29-31 / Basel, Switzerland